CHMP Backs Use of Generic Antiepileptic Lacosamide Accord CHMP Backs Use of Generic Antiepileptic Lacosamide Accord

The EMA committee recommends marketing authorization for Lacosamide Accord, the generic version of Vimpat, for treating partial-onset seizures in adults and teens.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news